We determined the kinetics of anti-SARS-CoV-2 antibody response in fifteen hospitalized COVID-19 patients. Patients were divided into mild/moderate (mild, n=1; moderate, n=4) or severe (n=10) and virus-specific anti-Nucleocapsid IgM, anti-Spike IgG and anti-Spike IgA were measured in serial serum samples collected 0-15 days after hospital admission. Surrogate neutralization assays were performed by testing inhibition of ACE-2 binding to Spike. In three patients (2 severe and 1 moderate case), serum antibodies and T-cell memory were monitored six months after baseline. Although IgM response tended to appear first, patients affected by less severe disease were more prone to an early IgG/IgA response. Neutralization of Spike binding to ACE2 correlated with anti-Spike IgG and IgA. IgG and IgA antibody response persisted at the six months follow-up. A recall T-cell response to the Spike antigen was observed in two out of three patients, not related to disease severity.

Early IgG / IgA response in hospitalized COVID-19 patients is associated with a less severe disease / Fedele, Giorgio; Russo, Gianluca; Schiavoni, Ilaria; Leone, Pasqualina; Olivetta, Eleonora; Perri, Valentina; Zingaropoli, Maria Antonella; Ciardi, Maria Rosa; Pasculli, Patrizia; Mastroianni, Claudio Maria; Stefanelli, Paola. - In: DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE. - ISSN 0732-8893. - 102:1(2021), pp. 1-6. [10.1016/j.diagmicrobio.2021.115586]

Early IgG / IgA response in hospitalized COVID-19 patients is associated with a less severe disease

Fedele, Giorgio
Co-primo
;
Russo, Gianluca
Co-primo
;
Perri, Valentina;Zingaropoli, Maria Antonella;Ciardi, Maria Rosa;Pasculli, Patrizia;Mastroianni, Claudio Maria;
2021

Abstract

We determined the kinetics of anti-SARS-CoV-2 antibody response in fifteen hospitalized COVID-19 patients. Patients were divided into mild/moderate (mild, n=1; moderate, n=4) or severe (n=10) and virus-specific anti-Nucleocapsid IgM, anti-Spike IgG and anti-Spike IgA were measured in serial serum samples collected 0-15 days after hospital admission. Surrogate neutralization assays were performed by testing inhibition of ACE-2 binding to Spike. In three patients (2 severe and 1 moderate case), serum antibodies and T-cell memory were monitored six months after baseline. Although IgM response tended to appear first, patients affected by less severe disease were more prone to an early IgG/IgA response. Neutralization of Spike binding to ACE2 correlated with anti-Spike IgG and IgA. IgG and IgA antibody response persisted at the six months follow-up. A recall T-cell response to the Spike antigen was observed in two out of three patients, not related to disease severity.
File allegati a questo prodotto
File Dimensione Formato  
Fedele_postprint_Early-IgG/IgA_2021.pdf

embargo fino al 06/09/2022

Tipologia: Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza: Creative commons
Dimensione 1.15 MB
Formato Adobe PDF
1.15 MB Adobe PDF Visualizza/Apri PDF
Fedele_Early-IgG/IgA_ 2022.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 1.05 MB
Formato Adobe PDF
1.05 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1569351
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 0
social impact